Fluconazole plus allopurinol in treatment of visceral leishmaniasis.
Torrús
D
D
Boix
V
V
Massa
B
B
Portilla
J
J
Pérez-Mateo
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy; D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001853:Bone Marrow / Q000382:microbiology; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation; D007898:Leishmaniasis, Visceral / Q000150:complications / Q000188:drug therapy*; D008297:Male
D000935:Antifungal Agents; D000963:Antimetabolites; D004791:Enzyme Inhibitors; D000493:Allopurinol; D015725:Fluconazole